Status:
COMPLETED
Low Dose Ketamine VR Analgesia During Burn Care Procedure
Lead Sponsor:
National Institute of General Medical Sciences (NIGMS)
Conditions:
Burn
Eligibility:
All Genders
18-85 years
Phase:
PHASE2
Brief Summary
The purpose of the research is to see whether a low dose of ketamine, a medication used to reduce pain, enhances the effectiveness of a virtual reality video game, which is used as a form of distracti...
Detailed Description
This study is conducted in a hospital setting. It is a randomized controlled trial comparing the use of virtual reality distraction (VRD) and standard pain medications to the use of VRD, standard pain...
Eligibility Criteria
Inclusion
- Age greater than or equal to 18 years
- Compliant and able to complete questionnaires
- No history of psychiatric disorder
- Not demonstrating delirium, psychosis or any form of Organic Brain Disorder
- Able to communicate verbally
- English-speaking
- IV access already in place
Exclusion
- Age less than 18 years
- Not capable of indicating pain intensity
- Not capable of filling out study measures
- Evidence of traumatic brain injury
- History of psychiatric disorder
- Demonstrating delirium, psychosis or any form of Organic Brain Disorder and associated memory problems
- Unable to communicate orally
- Receiving prophylaxis for alcohol or drug withdrawal
- Developmental disability
- Any face/head/neck injuries that interfere with the use of Virtual Reality equipment
- Non-English Speaking
- Extreme susceptibility to motion sickness
- Seizure history
- No IV access already in place
Key Trial Info
Start Date :
July 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2015
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT01889537
Start Date
July 1 2012
End Date
June 1 2015
Last Update
September 1 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Harborview Medical Center
Seattle, Washington, United States, 98104